Common patient profiles include: Busy professionals who want the benefits of NAD+ without blocking out half a day for an IV session Frequent travelers who need portable, consistent NAD+ support across time zones Active adults over 35 who are noticing slower recovery, lower energy, or reduced mental sharpness Longevity-focused individuals incorporating NAD+ into a broader healthy-aging protocol Athletes using injections to support recovery and cellular repair between training blocks Post-illness recovery patients who want structured cellular support as they return to baseline Existing IV therapy patients who want to maintain benefits between clinic visits NAD+ injections are not for everyone, and a medical evaluation is always the first step
In contrast to creams and co., hyaluronic acid from capsules reaches the tissues of the whole body
For users serious about measurable results with clinical backing, Hairgenetix remains the most evidence-backed option for Summer 2026
These findingsoriginating from landmark trials such as EMPA-REG OUTCOME, LEADER, and SUSTAIN-6have led to substantial revisions in international guidelines from the European Society of Cardiology, American College of Cardiology, and American Heart Association, which now recommend the use of SGLT2i or GLP-1 RAs, often in conjunction with metformin
The study, which evaluated data from more than 100,000 diabetes patients, found that those taking GLP-1s were upwards of 68 times more likely to develop NAION than those using other treatment methods
